Beijing Tong Ren Tang Chinese Medicine Company Limited
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. It operates through three segments: Hong Kong, Mainland China, and Overseas. The company offers Chinese medical consultation and treatment services. It also operates retail outlets in H… Read more
Market Cap & Net Worth: Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF)
Beijing Tong Ren Tang Chinese Medicine Company Limited (PINK:BJTRF) has a market capitalization of $542.78 Million ($542.78 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #16345 globally and #6301 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Beijing Tong Ren Tang Chinese Medicine Company Limited's stock price $0.65 by its total outstanding shares 837100000 (837.10 Million).
Beijing Tong Ren Tang Chinese Medicine Company Limited Market Cap History: 2021 to 2025
Beijing Tong Ren Tang Chinese Medicine Company Limited's market capitalization history from 2021 to 2025. Data shows growth from $134.44 Million to $542.78 Million (49.45% CAGR).
Beijing Tong Ren Tang Chinese Medicine Company Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Beijing Tong Ren Tang Chinese Medicine Company Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.34x
Beijing Tong Ren Tang Chinese Medicine Company Limited's market cap is 0.34 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
8.43x
Beijing Tong Ren Tang Chinese Medicine Company Limited's market cap is 8.43 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $134.44 Million | $199.55 Million | $77.94 Million | 0.67x | 1.72x |
| 2022 | $198.89 Million | $221.60 Million | $82.68 Million | 0.90x | 2.41x |
| 2023 | $262.85 Million | $195.29 Million | $540.39 Million | 1.35x | 0.49x |
| 2024 | $542.78 Million | $1.61 Billion | $64.38 Million | 0.34x | 8.43x |
Competitor Companies of BJTRF by Market Capitalization
Companies near Beijing Tong Ren Tang Chinese Medicine Company Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Beijing Tong Ren Tang Chinese Medicine Company Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Beijing Tong Ren Tang Chinese Medicine Company Limited Historical Marketcap From 2021 to 2025
Between 2021 and today, Beijing Tong Ren Tang Chinese Medicine Company Limited's market cap moved from $134.44 Million to $ 542.78 Million, with a yearly change of 49.45%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $542.78 Million | 0.00% |
| 2024 | $542.78 Million | +106.50% |
| 2023 | $262.85 Million | +32.15% |
| 2022 | $198.89 Million | +47.95% |
| 2021 | $134.44 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Beijing Tong Ren Tang Chinese Medicine Company Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $542.78 Million USD |
| MoneyControl | $542.78 Million USD |
| MarketWatch | $542.78 Million USD |
| marketcap.company | $542.78 Million USD |
| Reuters | $542.78 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.